Ram Ganapathi

Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance

Jean-Pierre Gillet, Anna Maria Calcagno, Sudhir Varma et al. · Proceedings of the National Academy of Sciences · 2011 · 474 citations · Full text

Medicine, Cancer Biology, Oncology +16

Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-κB-dependent mechanism of p53 suppression in tumors

Katerina V. Gurova, Jason E. Hill, Canhui Guo et al. · Proceedings of the National Academy of Sciences · 2005 · 264 citations · Full text

Medicine, Oncology, Pharmacology +14

von Hippel-Lindau Gene Status and Response to Vascular Endothelial Growth Factor Targeted Therapy for Metastatic Clear Cell Renal Cell Carcinoma

Toni K. Choueiri, S. A. Vaziri, Erich Jaeger et al. · The Journal of Urology · 2008 · 202 citations

Medicine, Cancer Biology, Oncology +12

Clear Cell Tubulopapillary Renal Cell Carcinoma: A Study of 36 Distinctive Low-grade Epithelial Tumors of the Kidney

Longwen Chen, Liang Cheng, S. A. Vaziri et al. · The American Journal of Surgical Pathology · 2010 · 200 citations

Medicine, Oncology, Pathology +16

Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.

Ram Ganapathi, Dale Grabowski · PubMed · 1983 · 167 citations

Medicine, Oncology, Pharmacology +17